Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 1/2011

01-12-2011 | Original Paper

Central nervous system involvement in Hodgkin’s lymphoma

Authors: L. Galán, A. C. Sánchez, B. Cantos, M. Provencio

Published in: Medical Oncology | Special Issue 1/2011

Login to get access

Abstract

Central nervous system involvement in Hodgkin´s lymphoma is extremely rare. We report three cases who had a relapse from the disease involving CNS. The most frequent causes are skull contiguity, meningeal invasion and via the hematogenous route. It is frequent that the association between Epstein–Barr Virus and Hodgkin´s lymphoma, and a biopsy for confirmation, is always required. Diagnostic imaging tests like CT and MRI are useful. The standard treatment remains holocraneal radiotherapy combined with chemotherapy.
Literature
1.
Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31:1860–1.PubMed
2.
Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol. 1989;7:1630–6.PubMed
3.
De Vita VT, Serpick A. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Proc Amer Ass Cancer Res. 1967;8:13.
4.
Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer. 1975;36:252–9.PubMedCrossRef
5.
Kaplan HS, Rosenberg SA. Extended field radical radiotherapy in advanced Hodgkin’s disease. Cancer Res. 1966;26:1268–76.PubMed
6.
Aragón de la Cruz G, Cardenes H, Otero J, et al. Individual risk of abdominal disease in patients with stages I and II supradiaphragmatic Hodgkin’s disease a rule index based on 341 laparotomized patients. Cancer. 1989;63:1799–803.PubMedCrossRef
7.
Johnson MD, Kinney MC, Scheithauer BW, Briley RJ, Hamilton K, Mc Person WF, Barton JH Jr. Primary intracerebral Hodgkin’s disease mimicking meningioma: Case report. Neurosurgery. 2000;47(2):454–6.PubMedCrossRef
8.
Cuttner J, Meyer R, Huang YP. Intracerebral involvement in Hodgkin’s disease: A report of 6 cases and review of the literature. Cancer. 1979;43(4):1497–506.PubMedCrossRef
9.
Biagi J, MacKenzie R, Lim MS, Sapp M, Berinstein N. Primary Hodgkin’s disease of the CNS in an immunocompetent patient: A case study review of the literature. Neuro-Oncology. 2000;2(4):239–43.PubMed
10.
Hirmiz K, Foyle A, Wilke D, Burrell S, Brownstone R, Ago C, et al. Intracranial presentation of systemic Hodgkin’s disease. Leukemia, Lymphoma. 2004;45(8):1667–71.CrossRef
11.
Sapozink MD, Kaplan HS. Intracraneal Hodgkin’s disease: A report of 12 cases and review of the literature. Cancer. 1983;52:1301–7.PubMedCrossRef
12.
Alvarez F, Road JM, Ancines B, Alvarez MP. Intracranial Hodgkin disease. J Neurosurg Sci. 1985;29:273–7.PubMed
13.
Ogata H, Karikomi M, Araki T, Uchiyama GA. Case of intracranial involvement of Hodgkin disease. Radiat Med. 1993;11:210–3.PubMed
14.
Klein R, Mullges W, Bendszus M, et al. Primary intracerebral Hodgkin’s disease: Report of a case with Epstein-Barr virus association and review of the literature. Am J Surg Pathol. 1999;23:477–81.PubMedCrossRef
15.
Apollonsky N, Edelman M, Johnson A, et al. Intracerebral presentation of Hodgkin disease mimicking meningioma in a young woman. J Pediatr Hematol Oncol. 2008;30:369–72.PubMedCrossRef
16.
Pansegrau, et al. Hodgkin’s Lymphoma involving the CNS. J Clin Oncol. 2007;25(11):1437–8.CrossRef
17.
Guermazi A, Brice P, Kerviler E, et al. Extranodal Hodgkin disease: Spectrum of disease. RadioGraphics. 2001;21:161–79.PubMed
18.
19.
Marshall G, Roessmann V, van den Noort S. Invasive Hodgkin’s disease of the brain. Report of 2 new cases and review of the American and European literature with clinical-pathological correlation. Cancer. 1968;2:621–30.CrossRef
20.
21.
Orlowski EP, Hansen RM, Anderson T, Hanson GA, Kun LE, Pisciotta AV. Hodgkin disease with leptomeningeal involvement, report of a case with long survival. Cancer. 1984;53:1833–5.PubMedCrossRef
22.
Chim CS, Shek TW, Ooi GC, Liang R. Unusual features of Hodgkin disease. Case 2: Meningeal relapse in Hodgkin disease. J Clin Oncol. 2000;18:1153–5.PubMed
23.
Vera R, Enriquez R, Papc R. Hodgkin’s disease, intracraneal involvement. Report of a case and review of the literature. Am J Clin Oncol. 1985;8:73–6.PubMedCrossRef
Metadata
Title
Central nervous system involvement in Hodgkin’s lymphoma
Authors
L. Galán
A. C. Sánchez
B. Cantos
M. Provencio
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue Special Issue 1/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9692-z

Other articles of this Special Issue 1/2011

Medical Oncology 1/2011 Go to the issue

Original paper

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

original paper

Immunohistochemical evidence for the over-expression of Glutathione peroxidase 3 in clear cell type ovarian adenocarcinoma

Original Paper

Antitumor efficacy of a photodynamic therapy-generated dendritic cell glioma vaccine

Original paper

Pegfilgrastim overdose: case report and review of the literature

Original paper

Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma

Original paper

CIDE-3 interacts with lipopolysaccharide-induced tumor necrosis factor, and overexpression increases apoptosis in hepatocellular carcinoma

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits